Semin intervent Radiol 2014; 31(01): 050-063
DOI: 10.1055/s-0033-1363843
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Percutaneous Ablation for Small Renal Masses—Imaging Follow-Up

Jason D. Iannuccilli
1   Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School, Brown University, Providence, Rhode Island
,
David J. Grand
1   Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School, Brown University, Providence, Rhode Island
,
Damian E. Dupuy
1   Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School, Brown University, Providence, Rhode Island
,
William W. Mayo-Smith
1   Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School, Brown University, Providence, Rhode Island
› Author Affiliations
Further Information

Publication History

Publication Date:
20 February 2014 (online)

Abstract

Image-guided percutaneous thermal ablation is a safe and effective nephron-sparing alternative to surgical resection for the treatment of small renal tumors. Assessment of treatment efficacy relies heavily on interval follow-up imaging after treatment. Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) both play a pivotal role in evaluating the treatment zone, identifying residual tumor, and detecting early and delayed procedure-related complications. This article discusses a surveillance imaging protocol for patients who undergo percutaneous thermal ablation of renal tumors, and also illustrates the typical appearances of both successfully treated tumors and residual disease on contrast-enhanced CT or MRI. In addition, it discusses the imaging appearance of potential early and delayed treatment-related complications to facilitate their prompt detection and management.

 
  • References

  • 1 American Cancer Society. Cancer Facts and Figures 2013. Altanta, GA: American Cancer Society; 2013
  • 2 Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol 1994; 152 (1) 39-42
  • 3 Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 2008; 19 (9) 1311-1320
  • 4 Salas N, Ramanathan R, Dummett S, Leveillee RJ. Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy. World J Urol 2010; 28 (5) 583-591
  • 5 Takaki H, Yamakado K, Soga N , et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol 2010; 28 (6) 460-468
  • 6 Thumar AB, Trabulsi EJ, Lallas CD, Brown DB. Thermal ablation of renal cell carcinoma: triage, treatment, and follow-up. J Vasc Interv Radiol 2010; 21 (8, Suppl): S233-S241
  • 7 Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60 (2) (Suppl. 01) 40-49
  • 8 Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217 (3) 633-646
  • 9 Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217 (3) 665-672
  • 10 Zagoria RJ, Hawkins AD, Clark PE , et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004; 183 (1) 201-207
  • 11 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226 (2) 417-424
  • 12 Pavlovich CP, Walther MM, Choyke PL , et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167 (1) 10-15
  • 13 Farrell MA, Charboneau WJ, DiMarco DS , et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003; 180 (6) 1509-1513
  • 14 Ahrar K, Matin S, Wood CG , et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol 2005; 16 (5) 679-688
  • 15 Clark TW, Malkowicz B, Stavropoulos SW , et al. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience. J Vasc Interv Radiol 2006; 17 (3) 513-519
  • 16 Breen DJ, Rutherford EE, Stedman B , et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol 2007; 30 (5) 936-942
  • 17 Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189 (2) 429-436
  • 18 Levinson AW, Su LM, Agarwal D , et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180 (2) 499-504 , discussion 504
  • 19 Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 2010; 24 (12) 1909-1913
  • 20 del Cura JL, Zabala R, Iriarte JI, Unda M. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications. Eur Urol 2010; 57 (3) 459-465
  • 21 Ganguli S, Brennan DD, Faintuch S, Rayan ME, Goldberg SN. Immediate renal tumor involution after radiofrequency thermal ablation. J Vasc Interv Radiol 2008; 19 (3) 412-418
  • 22 Rutherford EE, Cast JE, Breen DJ. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol 2008; 63 (2) 220-230
  • 23 Goldberg SN, Grassi CJ, Cardella JF , et al; Society of Interventional Radiology Technology Assessment Committee; International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235 (3) 728-739
  • 24 Matin SF, Ahrar K, Cadeddu JA , et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 2006; 176 (5) 1973-1977
  • 25 Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995; 197 (3) 589-597
  • 26 Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003; 180 (6) 1503-1508
  • 27 Su Li, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003; 61 (4) (Suppl. 01) 26-33
  • 28 Varkarakis IM, Allaf ME, Inagaki T , et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol 2005; 174 (2) 456-460 , discussion 460
  • 29 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (1) 64-71
  • 30 Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (1) 72-80
  • 31 Park SH, Yoon SK, Cho JH , et al. Radiofrequency ablation treatment for renal cell carcinoma: early clinical experience. Korean J Radiol 2008; 9 (4) 340-347
  • 32 Hiraoka K, Kawauchi A, Nakamura T, Soh J, Mikami K, Miki T. Radiofrequency ablation for renal tumors: our experience. Int J Urol 2009; 16 (11) 869-873
  • 33 Beland MD, Wolf FJ, Grand DJ, Dupuy DE, Mayo-Smith WW. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up. AJR Am J Roentgenol 2011; 197 (3) 671-675
  • 34 Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria RJ. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 2007; 27 (2) 325-339 , discussion 339–340
  • 35 Saliken J, Cohen J, Miller R, Rothert M. Laboratory evaluation of ice around a 3mm AccuProbe. Cryobiology 1995; 32: 285-295
  • 36 Remer EM, Weinberg EJ, Oto A, O'Malley CM, Gill IS. MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol 2000; 174 (3) 635-640
  • 37 Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics 2007; 27 (2) 343-355
  • 38 Javadi S, Ahrar JU, Ninan E, Gupta S, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 2010; 21 (5) 690-695
  • 39 Boss A, Clasen S, Kuczyk M , et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol 2005; 40 (9) 583-590
  • 40 Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 2005; 235 (3) 1065-1071
  • 41 Johnson DB, Solomon SB, Su LM , et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 2004; 172 (3) 874-877
  • 42 Beemster P, Phoa S, Wijkstra H, de la Rosette J, Laguna P. Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU Int 2008; 101 (10) 1237-1242
  • 43 Gill IS, Remer EM, Hasan WA , et al. Renal cryoablation: outcome at 3 years. J Urol 2005; 173 (6) 1903-1907
  • 44 Stein AJ, Mayes JM, Mouraviev V, Chen VH, Nelson RC, Polascik TJ. Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor. J Endourol 2008; 22 (11) 2433-2439
  • 45 Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics 2010; 30 (4) 887-900
  • 46 Harada J, Dohi M, Mogami T , et al. Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system. Radiat Med 2001; 19 (6) 291-296
  • 47 Matsumoto ED, Watumull L, Johnson DB , et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol 2004; 172 (1) 45-48
  • 48 Schirmang T, Mayo-Smith W, Dupuy D, Beland M, Grand D. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation—incidence and clinical importance in 101 consecutive patients. Radiology 2009; 251 (1) 263-269
  • 49 Kawamoto S, Solomon SB, Bluemke DA, Fishman EK. Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation. Semin Ultrasound CT MR 2009; 30 (2) 67-77
  • 50 Svatek RS, Sims R, Anderson JK, Abdel-Aziz K, Cadeddu JA. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology 2006; 67 (3) 508-512
  • 51 Davenport MS, Caoili EM, Cohan RH , et al. MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol 2009; 192 (6) 1571-1578
  • 52 Johnson DB, Saboorian MH, Duchene DA, Ogan K, Cadeddu JA. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology 2003; 62 (2) 351-352
  • 53 Maiwand MO. The role of cryosurgery in palliation of tracheo-bronchial carcinoma. Eur J Cardiothorac Surg 1999; 15 (6) 764-768
  • 54 Saremi F, Knoll AN, Bendavid OJ, Schultze-Haakh H, Narula N, Sarlati F. Characterization of genitourinary lesions with diffusion-weighted imaging. Radiographics 2009; 29 (5) 1295-1317
  • 55 Weight CJ, Kaouk JH, Hegarty NJ , et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008; 179 (4) 1277-1281 , discussion 1281–1283
  • 56 Boss A, Clasen S, Kuczyk M , et al. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. AJR Am J Roentgenol 2005; 185 (6) 1627-1631
  • 57 Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol 2009; 19 (9) 2180-2190
  • 58 Heye S, Maleux G, Van Poppel H, Oyen R, Wilms G. Hemorrhagic complications after nephron-sparing surgery: angiographic diagnosis and management by transcatheter embolization. AJR Am J Roentgenol 2005; 184 (5) 1661-1664
  • 59 Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 2008; 19 (9) 1311-1320
  • 60 Ginat DT, Saad WE. Bowel displacement and protection techniques during percutaneous renal tumor thermal ablation. Tech Vasc Interv Radiol 2010; 13 (2) 66-74
  • 61 Arellano RS, Garcia RG, Gervais DA, Mueller PR. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol 2009; 193 (6) 1686-1690
  • 62 DeBenedectis CM, Beland MD, Dupuy DE, Mayo-Smith WW. Utility of iodinated contrast medium in hydrodissection fluid when performing renal tumor ablation. J Vasc Interv Radiol 2010; 21 (5) 745-747
  • 63 Rhim H, Dodd III GD, Chintapalli KN , et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004; 24 (1) 41-52
  • 64 Kaur H, Matin SF, Javadi S , et al. Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 2011; 22 (7) 924-927